세계의 소비자 유전체학 시장 보고서(2025년)
Consumer Genomics Global Market Report 2025
상품코드 : 1821724
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

소비자 유전체학 시장 규모는 앞으로 수년간 비약적인 성장이 예상됩니다. 2029년에 CAGR은 21.0%를 나타낼 것으로 예측되고 89억 4,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 유전자 데이터 풀 확대, 질병 위험 평가 수요 증가, 웨어러블 기기와의 통합, 예방 의료로의 전환, 유전 상담 서비스 확대로 설명될 수 있습니다. 예측 기간의 주요 동향에는 유전 상담 서비스에 주력하는 점, 시퀀싱 비용 감소, 맞춤형 의약품의 부상, 소비자 직접 시험 수요 증가, 건강 및 웰빙 인식 제고가 포함됩니다.

향후 5년간 21.0% 성장이라는 예측은 이전 전망 대비 0.1% 소폭 하락한 수치입니다. 이 하락은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 장벽은 중국과 싱가포르에서 공급원되는 DNA 시퀀싱 칩 및 조상 분석 시약의 비용을 증가시켜 검사의 경제성을 감축하고 소비자 직접 시험 비용을 상승시킴으로써 미국 맞춤형 의약품 발전을 저해할 것으로 예상됩니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과가 더욱 광범위하게 나타날 것입니다.

맞춤형 의약품에 대한 관심이 증가함에 따라 향후 소비자 유전체학 시장 확장이 가속화될 것으로 전망됩니다. 이 의료 접근법은 개별 환자의 고유한 유전적, 환경적, 생활습관적 요소를 고려하여 맞춤형 치료 및 건강 관리 계획을 수립합니다. 유전자 연구의 발전, 건강 의식 고조, 부작용 감축을 위한 효과적인 치료법 추구 등이 맞춤형 의약품 수요 급증의 촉진요인입니다. 소비자 유전체학은 개인이 자신의 유전자 데이터에 접근할 수 있게 하여 정보에 기반한 건강 선택을 가능하게 하고 유전적 특성에 맞춘 치료를 추구할 수 있도록 함으로써 이러한 수요에서 핵심적인 역할을 수행합니다. 예를 들어, 2024년 2월 미국 비영리 단체인 맞춤형의학연합(Personalized Medicine Coalition)은 2023년 FDA가 희귀질환 환자를 위한 16개의 새로운 맞춤형 치료법을 승인했다고 보고했는데, 이는 2022년 6개에 비해 크게 증가한 수치입니다. 따라서 맞춤형 의약품에 대한 수요 증가는 소비자 유전체학 시장의 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Consumer genomics is a branch of genomics dedicated to providing genetic information directly to consumers, typically through commercial genetic testing services. These services utilize DNA samples submitted by individuals to generate reports containing information about genetic predispositions to specific traits, diseases, or conditions.

The primary products within the consumer genomics sector include consumables, systems and software, and other related products. In the context of consumer genomics, consumables encompass products and materials utilized in genetic testing, such as collection kits, reagents, and various laboratory supplies. The technologies employed in consumer genomics cover a range of methods, including polymerase chain reaction (PCR), sequencing, microarray, and nucleic acid extraction and purification. Applications of consumer genomics span genetic relatedness, diagnostics, lifestyle insights, ancestry tracing, wellness and nutrition recommendations, reproductive health assessments, personalized medicine and pharmacogenetic testing, sports nutrition and health, and other relevant areas.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The consumer genomics market research report is one of a series of new reports from The Business Research Company that provides consumer genomics optical components market statistics, including consumer genomics optical components industry global market size, regional shares, competitors with a consumer genomics optical components market share, detailed consumer genomics optical components market segments, market trends and opportunities, and any further data you may need to thrive in the consumer genomics optical components industry. This consumer genomics optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The consumer genomics market size has grown rapidly in recent years. It will grow from $3.5 billion in 2024 to $4.17 billion in 2025 at a compound annual growth rate (CAGR) of 19.2%. The growth in the historic period can be attributed to sequencing cost reduction, introduction of direct-to-consumer testing, pioneering companies in consumer genomics, data privacy and security concerns, initial adoption challenges.

The consumer genomics market size is expected to see exponential growth in the next few years. It will grow to $8.94 billion in 2029 at a compound annual growth rate (CAGR) of 21.0%. The growth in the forecast period can be attributed to expanded genetic data pool, increasing demand for disease risk assessment, integration with wearable devices, shift toward preventive healthcare, expansion of genetic counseling services. Major trends in the forecast period include focus on genetic counseling services, price reduction in sequencing, rise in personalized medicine, direct-to-consumer testing demand, health and wellness awareness.

The forecast of 21.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. personalized medicine by increasing the cost of Deoxyribonucleic acid(DNA) sequencing chips and ancestry analysis reagents sourced from China and Singapore, thereby reducing test affordability and elevating direct-to-consumer testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing interest in personalized medicine is anticipated to accelerate the expansion of the consumer genomics market in the future. This medical approach customizes treatment and healthcare plans to suit individual patients by considering their distinct genetic, environmental, and lifestyle elements. The surge in the need for personalized medicine is driven by advancements in genetic research, a rise in health awareness, and the quest for more effective therapies with reduced side effects. Consumer genomics plays a vital role in this demand by giving individuals access to their genetic data, enabling them to make knowledgeable health choices and pursue treatments tailored to their genetic traits. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, compared to just six in 2022. Thus, the increasing demand for personalized medicine is fueling the growth of the consumer genomics market.

The growth of the consumer genomics market is anticipated to be driven by the aging population in the coming years. An aging population is characterized by a rising number and proportion of older individuals, typically those aged 60 and above, alongside a declining number and percentage of younger individuals, usually those aged 15 and below. Consumer genomics contributes to understanding healthy aging, catering to the interests of older adults in genealogy testing, and offering insights into disease risks based on personal genetic profiles. For instance, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, projected that the number of Americans aged 65 and older would increase from 58 million in 2022 to 82 million by 2050, representing a 47% growth. Additionally, the share of this age group within the overall population is expected to rise from 17% to 23% during that timeframe. Thus, the aging population is a key factor driving the expansion of the consumer genomics market.

Leading companies in the consumer genomics market are concentrating on technological innovations, particularly analytical solutions, to enhance the interpretation of genomic data, enable quicker and more precise diagnoses, and support personalized medicine efforts. Analytical solutions encompass systematic methods or software tools aimed at processing and analyzing data, allowing organizations to extract valuable insights, recognize trends, and aid in decision-making. For example, in May 2024, SOPHiA GENETICS, a healthcare technology firm based in Switzerland, introduced a new whole genome sequencing (WGS) analytical solution. This cutting-edge technology examines the entire genetic makeup of an organism, providing comprehensive insights into its DNA sequence. The solution combines advanced computational tools, bioinformatics software, and cloud-based platforms to ensure the rapid processing and interpretation of extensive genomic data. By leveraging high-performance computing and artificial intelligence, WGS analytical solutions enable researchers and clinicians to obtain actionable insights quickly, often within a single day. This expedited analysis supports various applications, including personalized medicine and genetic research.

Major players in the consumer genomics market are directing efforts towards the introduction of advanced solutions, such as long-read sequencing systems, to gain a competitive advantage. Long-read sequencing, a form of next-generation sequencing (NGS), offers technical advantages over short-read sequencing for specific types of genetic variation detection. For instance, in October 2022, PacBio, a US-based biotechnology company, launched Revio, a groundbreaking long-read sequencing system. Leveraging advanced NGS technology and cutting-edge NVIDIA GPUs, Revio provides high-throughput, high-quality sequencing data. It is designed for applications in research and clinical settings, including large-scale studies in human genetics, cancer research, agricultural genomics, and more. The system incorporates deep learning algorithms to detect DNA methylation and DeepConsensus, a deep learning technique developed with Google Health to enhance the yield and accuracy of HiFi sequencing, offering accelerated basecalling to meet Revio's higher throughput.

In November 2022, Myriad Genetics, Inc., a US-based genetic testing company, acquired Gateway Genomics, LLC, for $67.5 million. This strategic acquisition enhances access to personalized genetic tests throughout and after a woman's reproductive stage, reinforcing Myriad Genetics' portfolio of women's health products. Gateway Genomics, a US-based personal genomics company and manufacturer of the SneakPeek early gender DNA test, adds valuable offerings to Myriad Genetics' genetic testing capabilities.

Major companies operating in the consumer genomics market include 23andMe Inc., Gene by Gene Ltd., Mapmygenome Ltd., Ancestry.com LLC, Color Genomics Inc., Futura Genetics LLC, Pathway Genomics Corporation, Helix Operating Company LLC, Positive Biosciences Corporation, Veritas Genetics Inc., Amgen Inc., Diagnomics Inc., Toolbox Genomics Inc., Xcode Life Sciences Inc., CircleDNA Inc., DNAfit Ltd., 24Genetics S.L.U., Living DNA Ltd., SelfDecode Inc., MyTrueAncestry Inc., WeGene Technology Co. Ltd., EasyDNA LLC, HomeDNA Inc., Gencove Inc., GenoMind Inc., Genos Inc., Nebula Genomics Corporation, Strategene Corporation

North America was the largest region in the consumer genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global consumer genomics market report during the forecast period. The regions covered in the consumer genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the consumer genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

Consumer genomics consists of revenue earned by entities that provide genetic testing services and revenue through various means including Direct-to-consumer (DTC) genetic testing kits, subscription-based services that provide access to ongoing genetic testing and analysis and pharmaceutical or biotechnology companies to provide access to their genetic data for research purposes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Consumer Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on consumer genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for consumer genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The consumer genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Consumer Genomics Market Characteristics

3. Consumer Genomics Market Trends And Strategies

4. Consumer Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Consumer Genomics Growth Analysis And Strategic Analysis Framework

6. Consumer Genomics Market Segmentation

7. Consumer Genomics Market Regional And Country Analysis

8. Asia-Pacific Consumer Genomics Market

9. China Consumer Genomics Market

10. India Consumer Genomics Market

11. Japan Consumer Genomics Market

12. Australia Consumer Genomics Market

13. Indonesia Consumer Genomics Market

14. South Korea Consumer Genomics Market

15. Western Europe Consumer Genomics Market

16. UK Consumer Genomics Market

17. Germany Consumer Genomics Market

18. France Consumer Genomics Market

19. Italy Consumer Genomics Market

20. Spain Consumer Genomics Market

21. Eastern Europe Consumer Genomics Market

22. Russia Consumer Genomics Market

23. North America Consumer Genomics Market

24. USA Consumer Genomics Market

25. Canada Consumer Genomics Market

26. South America Consumer Genomics Market

27. Brazil Consumer Genomics Market

28. Middle East Consumer Genomics Market

29. Africa Consumer Genomics Market

30. Consumer Genomics Market Competitive Landscape And Company Profiles

31. Consumer Genomics Market Other Major And Innovative Companies

32. Global Consumer Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Consumer Genomics Market

34. Recent Developments In The Consumer Genomics Market

35. Consumer Genomics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기